Bhagiradha Chemicals & Industries Limited
Fundamental Score
Bhagiradha Chemicals & Industries Limited Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of BHAGCHEM across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Revenue Growth (35.06%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (12.39% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (16.85% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (22.42% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.27)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (2.53%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (5.19%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Premium Valuation Risk (P/E: 259.49x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Negative Free Cash Flow (₹-419.63 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (19.60%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
Limited Institutional Interest (FII+DII: 2.94%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for Bhagiradha Chemicals & Industries Limited
About BHAGCHEM
Business Overview
Bhagiradha Chemicals & Industries Limited manufactures and sells crop protection chemicals in India, rest of Asia, Australia, Europe, and South America. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, imidacloprid, pymetrozine, and chlorantraniliprole; fungicides, including azoxystrobin and trifloxystrobin; herbicides comprising triclopyr, cloquintocet-mexyl, clodinafop-propargyl, sulfosulfuron, and pinoxaden; and specialty intermediates consisting of 2,6-dichloroaniline and 2-ethylsulfonylimidazo pyridine-3-sulfonamide. It serves agrochemical manufacturers and pesticide formulators and traders. The company was incorporated in 1993 and is headquartered in Hyderabad, India.
Company Details
Key Leadership
Corporate Events
BHAGCHEM Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Bhagiradha Chemicals & Industries Limited (BHAGCHEM)?
As of 29 Jan 2026, 10:34 am IST, Bhagiradha Chemicals & Industries Limited (BHAGCHEM) is currently trading at ₹201.82. The stock has a market capitalization of ₹3.16K (Cr).
Is BHAGCHEM share price Overvalued or Undervalued?
BHAGCHEM is currently trading at a P/E ratio of 259.49x, compared to the industry average of 29.36x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Bhagiradha Chemicals & Industries Limited share price?
Key factors influencing BHAGCHEM's price include its quarterly earnings growth (Sales Growth: 35.06%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Bhagiradha Chemicals & Industries Limited a good stock for long-term investment?
Bhagiradha Chemicals & Industries Limited shows a 5-year Profit Growth of 22.42% and an ROE of 2.53%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.27 before investing.
How does Bhagiradha Chemicals & Industries Limited compare with its industry peers?
Bhagiradha Chemicals & Industries Limited competes with major peers in the Pesticides & Agrochemicals. Investors should compare BHAGCHEM's P/E of 259.49x and ROE of 2.53% against the industry averages to determine its competitive standing.
What is the P/E ratio of BHAGCHEM and what does it mean?
BHAGCHEM has a P/E ratio of 259.49x compared to the industry average of 29.36x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹259 for every ₹1 of annual earnings.
How is BHAGCHEM performing according to Bull Run's analysis?
BHAGCHEM has a Bull Run fundamental score of 31.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does BHAGCHEM belong to?
BHAGCHEM operates in the Pesticides & Agrochemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Bhagiradha Chemicals & Industries Limited.
What is Return on Equity (ROE) and why is it important for BHAGCHEM?
BHAGCHEM has an ROE of 2.53%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Bhagiradha Chemicals & Industries Limited generates profits from shareholders' equity.
How is BHAGCHEM's debt-to-equity ratio and what does it indicate?
BHAGCHEM has a debt-to-equity ratio of 0.27, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is BHAGCHEM's dividend yield and is it a good dividend stock?
BHAGCHEM offers a dividend yield of 0.06%, which means you receive ₹0.06 annual dividend for every ₹100 invested.
How has BHAGCHEM grown over the past 5 years?
BHAGCHEM has achieved 5-year growth rates of: Sales Growth 12.39%, Profit Growth 22.42%, and EPS Growth 16.85%.
What is the promoter holding in BHAGCHEM and why does it matter?
Promoters hold 19.60% of BHAGCHEM shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is BHAGCHEM's market capitalization category?
BHAGCHEM has a market capitalization of ₹3163 crores, placing it in the Small-cap category.
How volatile is BHAGCHEM stock?
BHAGCHEM has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for BHAGCHEM?
BHAGCHEM has a 52-week high of ₹N/A and low of ₹N/A.
What is BHAGCHEM's operating profit margin trend?
BHAGCHEM has a 5-year average Operating Profit Margin (OPM) of 12.95%, indicating the company's operational efficiency.
How is BHAGCHEM's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 35.06% and YoY Profit Growth of 1.10%.
What is the institutional holding pattern in BHAGCHEM?
BHAGCHEM has FII holding of 0.05% and DII holding of 2.89%. Significant institutional holding often suggests professional confidence in the stock.